Nutriband Inc. Warrant (NTRBW)

About NTRBW

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in…

Sector

Health Care

Industry

Industrial Specialties

Website

www.nutriband.com

Fundamentals

1-day range

$0.45$0.48

Market cap

$4.25M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.51

Dividend yield

—

Beta

2.96

Avg. volume

2.6K

Nutriband Inc. Warrant Competitors

Chosen by industry and closest market cap.

• NTRBW

  Nutriband Inc. Warrant

  $0.45

  ▼ 35.71%
  Market cap $4.25MP/E —
  $0.25$2.99
• FEED

  ENvue Medical Inc. Common Stock

  $0.3366

  ▼ 8.53%
  Market cap $3.67MP/E —
  $0.29$17.4
• CLGN

  CollPlant Biotechnologies Ltd Ordinary Shares

  $0.345

  ▲ 18.97%
  Market cap $6.25MP/E —
  $0.2637$3.18
• HSCS

  HeartSciences Inc. Common Stock

  $3

  ▼ 3.85%
  Market cap $7.80MP/E —
• LFWD

  Lifeward Ltd. Ordinary Shares

  $7.46

  ▲ 1.29%
  Market cap $20.93MP/E —
  $4.14$10.56
• NTRB

  Nutriband Inc. Common Stock

  $4.51

  ▼ 2.49%
  Market cap $35.43MP/E —
  $2.8$8.63
• MAMO

  Massimo Group Common Stock

  $1

  ▲ 0.00%
  Market cap $44.56MP/E 16.57
  $0.85$5.59

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

197.5K

Total value held

$221.2K

Institutional holders

4